SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-264837
Filing Date
2020-10-06
Accepted
2020-10-06 17:18:54
Documents
2
Period of Report
2020-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d43206d8k.htm 8-K 40481
2 EX-2.1 d43206dex21.htm EX-2.1 519112
  Complete submission text file 0001193125-20-264837.txt   560777
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 201227531
SIC: 2834 Pharmaceutical Preparations